Echo Therapeutics, Inc.

CIK 1031927 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Echo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 7, 2021REVOKED9999999997-21-004656
Apr 21, 20178-K0001654954-17-003544
Apr 6, 2017SC 13D0001654954-17-003113
Mar 31, 2017NT 10-K0001654954-17-002904
Mar 23, 201740001415889-17-000476
Mar 23, 201740001415889-17-000478
Mar 22, 201740001415889-17-000472
Mar 22, 20178-K0001654954-17-002234
Mar 22, 201740001415889-17-000471
Feb 2, 20178-K0001654954-17-000706
Dec 27, 20168-K0001654954-16-005114
Dec 14, 20168-K0001654954-16-004834
Dec 2, 20168-K0001654954-16-004523
Dec 1, 20168-K0001654954-16-004467
Nov 23, 20168-K0001654954-16-004281
Nov 23, 20164/A0001415889-16-007497
Nov 16, 201610-Q0001654954-16-004120
Nov 14, 2016NT 10-Q0001415889-16-007398
Oct 19, 20168-K0001654954-16-002970
Sep 27, 20168-K0001654954-16-002394
Sep 26, 201625-NSE0001354457-16-000506
Sep 23, 20168-K0001415889-16-007193
Aug 12, 201610-Q0001415889-16-006793
Jul 8, 20168-K0001415889-16-006410
Jun 24, 2016EFFECT9999999995-16-005001